Celyad Oncology Announces Voluntary Pause of CYAD-101-002 Phase Ib Trial

Celyad Oncology SA announced it has taken the decision to voluntarily pause the CYAD-101-002 Phase Ib trial due to reports of two fatalities that presented with similar pulmonary findings.